Simultaneous Versus Staged Resection for Initially Resectable Synchronous Rectal Cancer Liver-lim… (NCT00677586) | Clinical Trial Compass
CompletedNot Applicable
Simultaneous Versus Staged Resection for Initially Resectable Synchronous Rectal Cancer Liver-limited Metastasis
180 participantsStarted 2010-07
Plain-language summary
The purpose of this study is to investigate the safety and efficacy of simultaneous liver resections compared to staged hepatectomies of rectal cancer with liver metastasis and to compare the short and long-term survival between the two groups.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* age\>=18 and \<= 75 years
* resectable primary rectal tumor
* remnant liver volume \>= 60%
* without other organ metastasis or peritoneum metastasis
* without contradiction of cardiac and pulmonary diseases
* American Society of Anesthesiologists (ASA) class I - II
* Histologically proved rectal adenocarcinoma
Exclusion Criteria:
* age \> 75 years
* unresectable primary rectal tumor
* remnant liver volume \< 60%
* with other organ metastasis or peritoneum metastasis
* with contradiction of cardiac and pulmonary diseases
* Tumors assessed as clinical complete response after preoperative radio- or chemoradiotherapy
* Signs of acute intestinal obstruction, bleeding or perforation needing emergency surgery
* Multiple colorectal tumors or other schedules needing for synchronous colon surgery
* Co-existent inflammatory bowel disease
* Pregnancy or lactation
* Patients received treatment other than preoperative radio- or chemoradiotherapy
What they're measuring
1
Severe complication rate after resection of primary and metastatic lesions